Cargando…

Hispanic representation in diabetes cardiovascular outcomes trials

OBJECTIVE: To examine Hispanic/Latino representation in diabetes cardiovascular outcomes trials for novel antidiabetic drugs. RESEARCH DESIGN AND METHODS: We compared Hispanic/Latino representation, age, gender and body mass index in diabetes cardiovascular outcomes trials published from January 200...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelley, A. Taylor, Mizokami-Stout, Kara, O'Brien, Matthew J., Bowen, Michael E., Sussman, Jeremy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557465/ https://www.ncbi.nlm.nih.gov/pubmed/31245007 http://dx.doi.org/10.1136/bmjdrc-2019-000656

Ejemplares similares

Prevalence of Metabolic Syndrome Among Hispanics/Latinos of Diverse Background: The Hispanic Community Health Study/Study of Latinos
por: Heiss, Gerardo, et al.
Publicado: (2014)

Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial
por: Davis, Stephen N., et al.
Publicado: (2019)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
por: Scott, Russell, et al.
Publicado: (2009)

Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis
por: Cardona, Andrea, et al.
Publicado: (2019)

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial
por: Persson, Frederik, et al.
Publicado: (2021)

Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
por: Basu, Sanjay, et al.
Publicado: (2018)

Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Impact of type 2 diabetes and microvascular complications on mortality and cardiovascular outcomes in a multiethnic Asian population
por: Yap, Jonathan, et al.
Publicado: (2021)

Effects of krill oil on endothelial function and other cardiovascular risk factors in participants with type 2 diabetes, a randomized controlled trial
por: Lobraico, Jessika M, et al.
Publicado: (2015)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
por: Brinck, Jonas, et al.
Publicado: (2022)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Soliman, Elsayed Z., et al.
Publicado: (2017)

Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
por: Shah, Baiju R., et al.
Publicado: (2008)

Genetic Risk Score Associations With Cardiovascular Disease and Mortality in the Diabetes Heart Study
por: Cox, Amanda J., et al.
Publicado: (2014)

Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India
por: Gupta, Arvind, et al.
Publicado: (2014)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study
por: Simó, Rafael, et al.
Publicado: (2019)

Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics
por: Youk, Tae Mi, et al.
Publicado: (2020)

Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study
por: Zhao, Maoxiang, et al.
Publicado: (2021)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
por: Birukov, Anna, et al.
Publicado: (2022)

Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
por: Perreault, Leigh, et al.
Publicado: (2014)

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
por: Longato, Enrico, et al.
Publicado: (2020)

Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort
por: Fu, Liyao, et al.
Publicado: (2022)

Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
por: Basu, Sanjay, et al.
Publicado: (2018)

Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
por: West, Nancy A., et al.
Publicado: (2009)

Heart Rate–Corrected QT Interval Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Diabetes Heart Study
por: Cox, Amanda J., et al.
Publicado: (2014)

PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
por: Buonaiuto, Giulia, et al.
Publicado: (2016)

Ideal Cardiovascular Health and the Prevalence and Progression of Coronary Artery Calcification in Adults With and Without Type 1 Diabetes
por: Alman, Amy C., et al.
Publicado: (2014)

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018)

Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
por: Sprenger, Lukas, et al.
Publicado: (2021)

Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study
por: An, Yali, et al.
Publicado: (2015)

Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
por: Ueki, Kohjiro, et al.
Publicado: (2016)

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk
por: Quek, Ruben G W, et al.
Publicado: (2015)

Use of an electronic health record to identify prevalent and incident cardiovascular disease in type 2 diabetes according to treatment strategy
por: Korytkowski, Mary T, et al.
Publicado: (2016)

Trigger finger is associated with risk of incident cardiovascular disease in individuals with type 2 diabetes: a retrospective cohort study
por: Mineoka, Yusuke, et al.
Publicado: (2021)

Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
por: Chowdhury, Mahin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_36cob6q1mhts4nfe1baitf7u61